ATHE — ALTERITY THERAPEUTICS LTD
As of Q2 2026, 4 SEC-registered investment managers reported holding ATHE (ALTERITY THERAPEUTICS LTD) in their latest 13F filings, with a combined reported value of $540.59K across 100.67K shares. That is +28.3% by share count (+22.21K shares) versus the previous quarter, while reported value moved +96.8%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 2 opened new positions, 2 added to existing stakes. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
ATHE is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Point72 Asset Management history | Q2 2025 | 131.43K | $537.34K | 0.00% | Hold |
| Morgan Stanley history | Q2 2026 | 63.06K | $338.66K | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 37.60K | $201.90K | 0.00% | Add |
| Geode Capital Management history | Q3 2022 | 12.13K | $5.00K | 0.00% | Hold |
| Wells Fargo & Co history | Q3 2021 | 2.50K | $3.00K | 0.00% | New |
| JPMorgan Chase & Co history | Q1 2025 | 53 | $184 | 0.00% | New |
| PNC Financial Services history | Q4 2022 | 400 | $140 | 0.00% | New |
| Millennium Management history | Q4 2022 | 96.84K | $34 | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 5 | $27 | 0.00% | New |
| Citigroup Inc history | Q2 2026 | 1 | $5 | 0.00% | New |
| Fidelity Management & Research (FMR) history | Q4 2022 | 1 | $0 | — | New |
New Positions (Q2 2026)
- UBS Group AG 5 sh · $27
- Citigroup Inc 1 sh · $5
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 11 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley | 568.96K | 559.86K | 579.96K | 595.26K | 546.96K | 524.36K | 53.48K | 52.19K | 51.48K | 55.08K | 51.98K | 48.40K | 44.50K | 44.40K | 43.70K | 58.30K | 68.68K | 63.68K | 58.38K | 63.06K |
| Citadel Advisors | 11.76K | — | 23.58K | — | — | — | — | — | — | — | 18.28K | — | 11.49K | — | — | — | 22.14K | 16.81K | 20.08K | 37.60K |
| UBS Group AG | — | 13.60K | 10.49K | — | — | — | — | — | 127 | — | 2 | 2 | 12.69K | 384 | 13.00K | — | — | — | — | 5 |
| Citigroup Inc | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 636 | 1 | — | 1 |
| Point72 Asset Management | — | — | — | — | — | — | — | — | — | — | — | — | — | 32.63K | 131.43K | 131.43K | — | — | — | — |
| Fidelity Management & Research (FMR) | — | — | — | — | — | 1 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 53 | — | — | — | — | — |
| Geode Capital Management | 12.13K | 12.13K | 12.13K | 12.13K | 12.13K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Millennium Management | — | — | — | — | 13.21K | 96.84K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| PNC Financial Services | — | — | — | — | — | 400 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Wells Fargo & Co | 2.50K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details